Gui Fu Zhang
Directeur/Membre du Conseil chez New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
Profil
Gui Fu Zhang is currently an Executive Director at China Pharmaceutical Co. Ltd., CMP Group Ltd.
(Samoa), and New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
In the past, she worked as an Executive Director at SSY Group Ltd.
from 2010 to 2012 and as an Executive Director & Finance Manager at Shijiazhuang No.
4 Pharmaceutical Co., Ltd.
from 2011 to 2013.
Postes actifs de Gui Fu Zhang
| Sociétés | Poste | Début |
|---|---|---|
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
 New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. Financial ConglomeratesFinance Part of SSY Group Ltd., New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. operates as an investment holding Samoan company. The company is based in Chaoyan, Samoa. New Orient Investments Pharmaceutical Holding (Hong Kong was acquired by SSY Group Ltd. from CMP Group Ltd. (Samoa) on June 29, 2007 for $91.31 million. | Directeur/Membre du Conseil | 23/03/2010 |
China Pharmaceutical Co. Ltd.
 China Pharmaceutical Co. Ltd. Financial ConglomeratesFinance China Pharmaceutical Co. Ltd. operates as an investment holding Chinese company. | Directeur/Membre du Conseil | 09/09/2011 |
CMP Group Ltd. (Samoa)
 CMP Group Ltd. (Samoa) Financial ConglomeratesFinance Part of China Pharmaceutical Co. Ltd., CMP Group Ltd. (Samoa) operates a Samoan investment company. | Directeur/Membre du Conseil | 09/09/2011 |
Anciens postes connus de Gui Fu Zhang
| Sociétés | Poste | Fin |
|---|---|---|
| SSY GROUP LIMITED | Directeur/Membre du Conseil | 05/04/2012 |
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
 Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN. | Directeur Financier/CFO | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SSY GROUP LIMITED | Health Technology |
| Entreprise privées | 4 |
|---|---|
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN. | Health Technology |
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. Financial ConglomeratesFinance Part of SSY Group Ltd., New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. operates as an investment holding Samoan company. The company is based in Chaoyan, Samoa. New Orient Investments Pharmaceutical Holding (Hong Kong was acquired by SSY Group Ltd. from CMP Group Ltd. (Samoa) on June 29, 2007 for $91.31 million. | Finance |
China Pharmaceutical Co. Ltd.
China Pharmaceutical Co. Ltd. Financial ConglomeratesFinance China Pharmaceutical Co. Ltd. operates as an investment holding Chinese company. | Finance |
CMP Group Ltd. (Samoa)
CMP Group Ltd. (Samoa) Financial ConglomeratesFinance Part of China Pharmaceutical Co. Ltd., CMP Group Ltd. (Samoa) operates a Samoan investment company. | Finance |
